SCHEMBL13446904

SCHEMBL13446904

OC[C@H]1O[C@@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SLC5A2 P31639 5/20 0.55
▸ SYNJ2 O15056 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ ABL1 P00519 1/20 0.46
▸ ALPL P05186 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ ALPI P09923 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ALPG P10696 1/20 0.46
▸ PABPC1 P11940 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ GALK1 P51570 1/20 0.46
▸ CASP7 P55210 1/20 0.46
▸ CASP6 P55212 1/20 0.46
▸ MCL1 Q07820 1/20 0.46
▸ RIN1 Q13671 1/20 0.46
▸ EIF4H Q15056 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7147747 0.98 SLC5A2 (0.53) SLC5A2SYNJ2KDM4EABL1ALPL
SCHEMBL12582923 0.98 SLC5A2 (0.53) SLC5A2SYNJ2KDM4EABL1ALPL
SCHEMBL12459457 0.98 SLC5A2 (0.53) SLC5A2SYNJ2KDM4EABL1ALPL
SCHEMBL15820966 0.85 SLC5A2 (0.51) SLC5A2
SCHEMBL15820964 0.85 SLC5A2 (0.51) SLC5A2
SCHEMBL12459459 0.84 SLC5A2 (0.44) SLC5A2SYNJ2
SCHEMBL12582958 0.84 SLC5A2 (0.44) SLC5A2SYNJ2
SCHEMBL8310780 0.84 TSHR (0.42) SLC5A2
SCHEMBL5195874 0.84 TSHR (0.42) SLC5A2
SCHEMBL5195871 0.84 TSHR (0.42) SLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101255178-A C-glycoside and C-glycoside compound containing substituted aromatic rings as well as preparation and use thereofb RADIATION MEDICAL INST PLA ACA (CN) 2008-09-03 — — CN claimed
EP-2168972-A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity Kemin Pharma Europe (US) 2010-03-31 — — EP disclosed
US-7534871-B2 Carbohydrate scaffold, carrying two side chains, which form a macrocyclic ring that may be unsaturated and contains ether, amide, ester and/or carbamate groups; for therapy of bacterial, fungal, viral or protozoal infections or tumors KEMIN PHARMA B.V.B.A. (US) 2009-05-19 — — US disclosed
CN-101255178-A C-glycoside and C-glycoside compound containing substituted aromatic rings as well as preparation and use thereofb RADIATION MEDICAL INST PLA ACA (CN) 2008-09-03 — — CN disclosed
Send feedback